Letters Lipid lowering drugs in diabetes: Lipid lowering has ophthalmic benefits BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7552.1272-b (Published 25 May 2006) Cite this as: BMJ 2006;332:1272 Article Related content Metrics Responses Peer review Related articles Research Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials Published: 11 May 2006; BMJ 332 doi:10.1136/bmj.38793.468449.AE RESEARCH Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials Published: 24 April 2006; BMJ doi:10.1136/bmj.38793.468449.AE RESEARCH Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials Published: 03 April 2006; BMJ doi:10.1136/bmj.38793.468449.AE See more Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test BMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744 FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is key BMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102